|
JPS5522636A
(en)
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
|
US4582839A
(en)
|
1984-03-21 |
1986-04-15 |
Takeda Chemical Industries, Ltd. |
2,4-thiazolidinediones
|
|
WO1985004170A1
(fr)
|
1984-03-21 |
1985-09-26 |
Takeda Chemical Industries, Ltd. |
Derives de thiazolidinedione, leur procede de preparation et compositions medicinales les contenant
|
|
WO1986002073A1
(fr)
|
1984-10-03 |
1986-04-10 |
Takeda Chemical Industries, Ltd. |
Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
|
|
CN1003445B
(zh)
|
1984-10-03 |
1989-03-01 |
武田药品工业株式会社 |
噻唑烷二酮衍生物，其制备方法和用途
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US5167228A
(en)
|
1987-06-26 |
1992-12-01 |
Brigham And Women's Hospital |
Assessment and modification of endogenous circadian phase and amplitude
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5143930A
(en)
|
1990-02-07 |
1992-09-01 |
Sankyo Company, Limited |
Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
|
|
US5356913A
(en)
|
1990-02-09 |
1994-10-18 |
The Upjohn Company |
Use of insulin sensitizing agents to treat hypertension
|
|
US5441971A
(en)
|
1991-04-11 |
1995-08-15 |
The Upjohn Company |
Thiazolidinedione derivatives, production and use thereof
|
|
DE69231886T2
(de)
|
1991-04-11 |
2002-03-28 |
Pharmacia & Upjohn Co., Kalamazoo |
Thiazolidindionderivate, herstellung und anwendung
|
|
NO302471B1
(no)
|
1991-12-26 |
1998-03-09 |
Sankyo Co |
Tiazolidinforbindelser og farmasöytisk preparat
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
TWI238064B
(en)
*
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
IL118778A
(en)
|
1995-07-03 |
1999-07-14 |
Sankyo Co |
Pharmaceutical compositions for the treatment of arteriosclerosis and xanthoma containing an hmg-coa reductase inhibitor
|
|
US7407978B2
(en)
|
1999-04-06 |
2008-08-05 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
|
EP1210087A2
(en)
|
1999-04-29 |
2002-06-05 |
City of Hope |
Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
|
|
US6331596B1
(en)
|
1999-06-28 |
2001-12-18 |
Basf Corporation |
Method of preparing carbamate-functional polymers
|
|
MXPA01013199A
(es)
|
1999-06-30 |
2003-08-20 |
Tularik Inc |
Compuestos para la modulacion de la actividad de ppary.
|
|
AU6118001A
(en)
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
|
AU2002226365A1
(en)
|
2000-12-01 |
2002-06-11 |
Novartis Ag |
Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
|
|
US7009057B2
(en)
|
2001-04-26 |
2006-03-07 |
Zentiva A.S. |
Method for obtaining pioglitazone as an antidiabetic agent
|
|
US7135485B2
(en)
|
2001-09-28 |
2006-11-14 |
Teva Pharmaceutical Industries Ltd. |
Pioglitazone hydrochloride
|
|
AUPS236902A0
(en)
|
2002-05-16 |
2002-06-13 |
Northern Sydney Area Health Service |
Composition and method for treating hypertension
|
|
WO2004007490A2
(en)
|
2002-07-16 |
2004-01-22 |
Cadila Healthcare Limited |
A process to prepare pioglitazone via several intermediates.
|
|
US20060083784A1
(en)
|
2002-08-07 |
2006-04-20 |
Smithkline Beecham Corporation |
Amorphous pharmaceutical compositions
|
|
US7230016B2
(en)
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
|
US20070078170A1
(en)
|
2003-08-28 |
2007-04-05 |
Khanduri Chandra H |
Process for the preparation of pioglitazone
|
|
AR047541A1
(es)
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
JP4475983B2
(ja)
|
2004-03-03 |
2010-06-09 |
学校法人日本大学 |
Ｂｍａｌ１を阻害する方法
|
|
AU2005288080B2
(en)
|
2004-09-28 |
2011-10-13 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril compound
|
|
PL2001468T3
(pl)
*
|
2006-03-16 |
2013-03-29 |
Metabolic Solutions Dev Co Llc |
Analogi tiazolidynodionu
|
|
JP2009530293A
(ja)
|
2006-03-16 |
2009-08-27 |
メタボリック ソリューションズ ディベロップメント カンパニー |
チアゾリジンジオン類似体およびグルココルチコイドアゴニストの併用療法
|
|
NZ571870A
(en)
|
2006-03-16 |
2011-07-29 |
Metabolic Solutions Dev Co |
Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
|
|
US8304441B2
(en)
|
2007-09-14 |
2012-11-06 |
Metabolic Solutions Development Company, Llc |
Thiazolidinedione analogues for the treatment of metabolic diseases
|
|
KR101537830B1
(ko)
|
2007-09-14 |
2015-07-17 |
메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 |
고혈압 치료용 티아졸리딘디온 유사체
|
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
|
NZ590774A
(en)
*
|
2008-08-07 |
2012-09-28 |
Pulmagen Therapeutics Inflammation Ltd |
Substantially pure 5R enantiomers of pioglitazone and rosiglitazone for treating inflammatory respiratory diseases
|
|
WO2010105048A1
(en)
|
2009-03-12 |
2010-09-16 |
Metabolic Solutions Development Company |
Thiazolidinedione analogues
|
|
WO2011017244A1
(en)
|
2009-08-05 |
2011-02-10 |
Metabolic Solutions Development Company |
Polymorphs of 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)-1,3-thiazolidine-2,4-dione (mitoglitazone)
|
|
US20130053350A1
(en)
|
2009-12-15 |
2013-02-28 |
Metabolic Solutions Development Company, Llc |
Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
|
|
KR20120107493A
(ko)
|
2009-12-15 |
2012-10-02 |
메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 |
대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염
|
|
CA2783262A1
(en)
|
2009-12-15 |
2011-07-14 |
Metabolic Solutions Development Company, Llc |
Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases
|
|
US20120322728A1
(en)
|
2009-12-15 |
2012-12-20 |
Metabolic Solutions Development Company, Llc |
Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
|
|
JP2013525362A
(ja)
|
2010-04-21 |
2013-06-20 |
メタボリック ソリューションズ ディベロップメント カンパニー， エルエルシー |
チアゾリジンジオン類似体
|